Development and rigorous validation of antimalarial predictive models using machine learning approaches
暂无分享,去创建一个
G Madhukar | Danishuddin | M Z Malik | N Subbarao | N. Subbarao | M. Malik | G. Madhukar | M.Z. Malik
[1] Guillaume J Filion,et al. The signed Kolmogorov-Smirnov test: why it should not be used , 2015, GigaScience.
[2] Teuvo Kohonen,et al. Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.
[3] Amit Kumar,et al. Development of Ligand and Structure-based classification models to design novel inhibitors against antibiotic hydrolyzing enzymes: Integration of web server , 2018, Journal of biomolecular structure & dynamics.
[4] Ewout W Steyerberg,et al. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests , 2016, British Medical Journal.
[5] Teuvo Kohonen,et al. Essentials of the self-organizing map , 2013, Neural Networks.
[6] Mahdi Pakdaman Naeini,et al. Binary classifier calibration using an ensemble of piecewise linear regression models , 2017, Knowledge and Information Systems.
[7] Rajarshi Guha,et al. A survey of quantitative descriptions of molecular structure. , 2012, Current topics in medicinal chemistry.
[8] Piotr F J Lipiński,et al. SCRAMBLE’N’GAMBLE: a tool for fast and facile generation of random data for statistical evaluation of QSAR models , 2017, Chemical Papers.
[9] Thomas G. Dietterich. What is machine learning? , 2020, Archives of Disease in Childhood.
[10] D. Fidock,et al. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic , 2017, Nature Medicine.
[11] Gunnar Rätsch,et al. Active Learning with Support Vector Machines in the Drug Discovery Process , 2003, J. Chem. Inf. Comput. Sci..
[12] Paul D Lyne,et al. Structure-based virtual screening: an overview. , 2002, Drug discovery today.
[13] Alex Alves Freitas,et al. A novel applicability domain technique for mapping predictive reliability across the chemical space of a QSAR: reliability-density neighbourhood , 2016, Journal of Cheminformatics.
[14] Ramón García-Domenech,et al. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. , 2006, The Journal of antimicrobial chemotherapy.
[15] A. Christoffels,et al. Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs , 2016, Malaria Journal.
[16] George D. Magoulas,et al. Extensions of the k Nearest Neighbour methods for classification problems , 2008 .
[17] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[18] Yingye Zheng,et al. Integrating the predictiveness of a marker with its performance as a classifier. , 2007, American journal of epidemiology.
[19] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[20] Tian Zhu,et al. Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. , 2013, Journal of medicinal chemistry.
[21] Joseph L. Gastwirth,et al. The binary regression quantile plot : Assessing the importance of predictors in binary regression visually , 2001 .
[22] U. Bandyopadhyay,et al. Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones , 2016, Antimicrobial Agents and Chemotherapy.
[23] Matthieu Montes,et al. Predictiveness curves in virtual screening , 2015, Journal of Cheminformatics.
[24] Miriam Mathea,et al. Efficiency of different measures for defining the applicability domain of classification models , 2017, Journal of Cheminformatics.
[25] Aixia Guo,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2014 .
[26] Andrew P. Bradley,et al. The use of the area under the ROC curve in the evaluation of machine learning algorithms , 1997, Pattern Recognit..
[27] M. Markowicz,et al. Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests , 2011, International journal of molecular sciences.
[28] G. Mangiatordi,et al. Applicability Domain for QSAR models: where theory meets reality , 2016 .
[29] Min Wang,et al. Prediction of antibacterial compounds by machine learning approaches , 2009, J. Comput. Chem..
[30] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[31] Xiao-Hua Zhou,et al. Partial summary measures of the predictiveness curve , 2013, Biometrical journal. Biometrische Zeitschrift.
[32] J. Augereau,et al. Plasmodium falciparum: multifaceted resistance to artemisinins , 2016, Malaria Journal.
[33] A. Yan,et al. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors , 2016, SAR and QSAR in environmental research.
[34] Ziding Feng,et al. Evaluating the Predictiveness of a Continuous Marker , 2007, Biometrics.
[35] W. Peters. Drug resistance in malaria parasites of animals and man. , 1998, Advances in parasitology.
[36] Samuel Egieyeh,et al. Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach , 2018, PloS one.
[37] Gerta Rücker,et al. y-Randomization and Its Variants in QSPR/QSAR , 2007, J. Chem. Inf. Model..
[38] Andreas Zell,et al. Kernel-based estimation of the applicability domain of QSAR models , 2010, J. Cheminformatics.
[39] E. Ashley,et al. Artemisinin resistance – modelling the potential human and economic costs , 2014, Malaria Journal.
[40] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[41] David DeCaprio,et al. Cheminformatics approaches to analyze diversity in compound screening libraries. , 2010, Current opinion in chemical biology.
[42] Juan J Perez,et al. Managing molecular diversity. , 2005, Chemical Society reviews.
[43] J. Broach,et al. High-throughput screening for drug discovery. , 1996, Nature.
[44] György M Keseru,et al. Hit discovery and hit-to-lead approaches. , 2006, Drug discovery today.
[45] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[46] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[47] José L Medina-Franco,et al. Activity Cliffs: Facts or Artifacts? , 2013, Chemical biology & drug design.